JSMC
MNOV icon

Jess S. Morgan & Co’s MediciNova MNOV Stock Holding History

Jess S. Morgan & Co’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-498,688
Closed -$2.52M – 42
2021
Q1 		$2.52M Buy
498,688
+142,970
+40% +$832K 1.76% 34
2020
Q4 		$1.87M Buy
355,718
+3,743
+1% +$21.4K 1.49% 33
2020
Q3 		$1.84M Buy
+351,975
New +$2.03M 1.84% 33

Other funds holding MNOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jess S. Morgan & Co's MNOV Position: Q2 2021 in Review

Jess S. Morgan & Co sold out of MediciNova (MNOV) in Q2 2021, closing a stake of 498,688 shares — an estimated $2.52M sold.

Jess S. Morgan & Co first reported a position in MNOV in Q3 2020 and held it in 3 quarters. The position peaked at $2.52M in Q1 2021. 55 funds tracked by Wall St. Rank hold MNOV as of Q2 2021.

  • Jess S. Morgan & Co reported no remaining MediciNova position as of Q2 2021 after selling out during the quarter.
  • Jess S. Morgan & Co sold 498,688 MediciNova shares in Q2 2021, an estimated $2.52M.
  • Jess S. Morgan & Co first reported a position in MediciNova in Q3 2020 and held it in 3 quarters.
  • Jess S. Morgan & Co's MediciNova position peaked at $2.52M in Q1 2021.
  • 55 funds tracked by Wall St. Rank held MediciNova as of Q2 2021.

Based on Jess S. Morgan & Co's 13F filing for Q2 2021, filed 30 Nov 2021.